{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:42:40Z","timestamp":1790793760709,"version":"4.1.0"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"15","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA117907"],"award-info":[{"award-number":["CA117907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005508","name":"Boettcher Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005508","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Liposarcoma is the most commonly occurring soft-tissue sarcoma and is frequently characterized by amplification of chromosome region 12q13\u201315 harboring the oncogenes MDM2 and CDK4. This unique genetic profile makes liposarcoma an attractive candidate for targeted therapeutics. While CDK4\/6 inhibitors are currently employed for treatment of several cancers, MDM2 inhibitors have yet to attain clinical approval. Here, we report the molecular characterization of the response of liposarcoma to the MDM2 inhibitor nutlin-3. Treatment with nutlin-3 led to upregulation of two nodes of the proteostasis network: the ribosome and the proteasome. CRISPR\/Cas9 was used to perform a genome-wide loss of function screen that identified PSMD9, which encodes a proteasome subunit, as a regulator of response to nutlin-3. Accordingly, pharmacologic studies with a panel of proteasome inhibitors revealed strong combinatorial induction of apoptosis with nutlin-3. Mechanistic studies identified activation of the ATF4\/CHOP stress response axis as a potential node of interaction between nutlin-3 and the proteasome inhibitor carfilzomib. CRISPR\/Cas9 gene editing experiments confirmed that ATF4, CHOP, and the BH3-only protein, NOXA, are all required for nutlin-3 and carfilzomib-induced apoptosis. Furthermore, activation of the unfolded protein response using tunicamycin and thapsigargin was sufficient to activate the ATF4\/CHOP stress response axis and sensitize to nutlin-3. Finally, cell line and patient-derived xenograft models demonstrated combinatorial effects of treatment with idasanutlin and carfilzomib on liposarcoma growth in vivo. Together, these data indicate that targeting of the proteasome could improve the efficacy of MDM2 inhibitors in liposarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Targeting the proteasome in combination with MDM2 inhibition activates the ATF4\/CHOP stress response axis to induce apoptosis in liposarcoma, providing a potential therapeutic approach for the most common soft-tissue sarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-22-3173","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:08:55Z","timestamp":1684501735000},"page":"2543-2556","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4\/CHOP Stress Response Pathway"],"prefix":"10.1158","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5961-1490","authenticated-orcid":false,"given":"Michael P.","family":"Ludwig","sequence":"first","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"2Department of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-3927","authenticated-orcid":false,"given":"Matthew D.","family":"Galbraith","sequence":"additional","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6351-0051","authenticated-orcid":false,"given":"Neetha Paul","family":"Eduthan","sequence":"additional","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9392-1717","authenticated-orcid":false,"given":"Amanda A.","family":"Hill","sequence":"additional","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-8927","authenticated-orcid":false,"given":"Michael R.","family":"Clay","sequence":"additional","affiliation":[{"name":"4Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8064-0865","authenticated-orcid":false,"given":"Cristiam Moreno","family":"Tellez","sequence":"additional","affiliation":[{"name":"5Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-497X","authenticated-orcid":false,"given":"Breelyn A.","family":"Wilky","sequence":"additional","affiliation":[{"name":"5Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6509-9211","authenticated-orcid":false,"given":"Anthony","family":"Elias","sequence":"additional","affiliation":[{"name":"5Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-1941","authenticated-orcid":false,"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-0205","authenticated-orcid":false,"given":"Kelly D.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"2Department of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"2025112418000325700_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-3329-2-14","article-title":"The epidemiology of sarcoma","volume":"2","author":"Burningham","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"2025112418000325700_bib2","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2025112418000325700_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1200\/JCO.2017.74.9598","article-title":"Clinical and molecular spectrum of liposarcoma","volume":"36","author":"Lee","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025112418000325700_bib4","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.ejca.2005.07.023","article-title":"Differential sensitivity of liposarcoma subtypes to chemotherapy","volume":"41","author":"Jones","year":"2005","journal-title":"Eur J Cancer"},{"key":"2025112418000325700_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/SLA.0b013e3181b2468b","article-title":"Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule","volume":"250","author":"Park","year":"2009","journal-title":"Ann Surg"},{"key":"2025112418000325700_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2025112418000325700_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumor types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2025112418000325700_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/labinvest.2010.185","article-title":"An experimental model for the study of well-differentiated and de-differentiated liposarcoma; deregulation of targetable tyrosine kinase receptors","volume":"91","author":"Peng","year":"2011","journal-title":"Lab Invest"},{"key":"2025112418000325700_bib9","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-022-30496-0","article-title":"Clinical genomic profiling in the management of patients with soft-tissue and bone sarcoma","volume":"13","author":"Gounder","year":"2022","journal-title":"Nat Commun"},{"key":"2025112418000325700_bib10","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1038\/s41467-022-30453-x","article-title":"Clinical sequencing of soft-tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets","volume":"13","author":"Nacev","year":"2022","journal-title":"Nat Commun"},{"key":"2025112418000325700_bib11","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1101\/gr.220533.117","article-title":"Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity","volume":"27","author":"Andrysik","year":"2017","journal-title":"Genome Res"},{"key":"2025112418000325700_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nchembio.965","article-title":"ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53","volume":"8","author":"Sullivan","year":"2012","journal-title":"Nat Chem Biol"},{"key":"2025112418000325700_bib13","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.3390\/ijms221910883","article-title":"At a crossroads to cancer: how p53-induced cell fate decisions secure genome integrity","volume":"22","author":"Rizzotto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025112418000325700_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025112418000325700_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","article-title":"Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or de-differentiated liposarcoma: an exploratory proof-of-mechanism study","volume":"13","author":"Ray-Coquard","year":"2012","journal-title":"Lancet Oncol"},{"key":"2025112418000325700_bib16","doi-asserted-by":"crossref","first-page":"12609","DOI":"10.1038\/ncomms12609","article-title":"TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma","volume":"7","author":"Jung","year":"2016","journal-title":"Nat Commun"},{"key":"2025112418000325700_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13058-020-01318-2","article-title":"MDM2 inhibition in combination with endocrine therapy and CDK4\/6 inhibition for the treatment of ER-positive breast cancer","volume":"22","author":"Portman","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2025112418000325700_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s40425-019-0750-6","article-title":"MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment","volume":"7","author":"Fang","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2025112418000325700_bib19","doi-asserted-by":"crossref","first-page":"69779","DOI":"10.18632\/oncotarget.19266","article-title":"Combination treatment with rucaparib (rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer","volume":"8","author":"Zanjirband","year":"2017","journal-title":"Oncotarget"},{"key":"2025112418000325700_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/bioinformatics\/btq057","article-title":"Fast and SNP-tolerant detection of complex variants and splicing in short reads","volume":"26","author":"Wu","year":"2010","journal-title":"Bioinformatics"},{"key":"2025112418000325700_bib21","article-title":"Haplotype-based variant detection from short-read sequencing","volume-title":"arxiv","author":"Garrison","year":"2012"},{"key":"2025112418000325700_bib22","doi-asserted-by":"crossref","first-page":"e0185056","DOI":"10.1371\/journal.pone.0185056","article-title":"BBMerge - accurate paired shotgun read merging via overlap","volume":"12","author":"Bushnell","year":"2017","journal-title":"PLoS One"},{"key":"2025112418000325700_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025112418000325700_bib24","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025112418000325700_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2025112418000325700_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"2025112418000325700_bib27","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"key":"2025112418000325700_bib28","volume-title":"RStudio: Integrated Development for R","author":"RStudio Team","year":"2020"},{"key":"2025112418000325700_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025112418000325700_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"2025112418000325700_bib31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat Protoc"},{"key":"2025112418000325700_bib32","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"2025112418000325700_bib33","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","article-title":"GSEA-P: a desktop application for gene set enrichment analysis","volume":"23","author":"Subramanian","year":"2007","journal-title":"Bioinformatics"},{"key":"2025112418000325700_bib34","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.3390\/ijms222111595","article-title":"Proteasome inhibitors and their pharmacokinetics, pharmacodynamics, and metabolism","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025112418000325700_bib35","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmb.100","article-title":"Generating single cell-derived knockout clones in mammalian cells with CRISPR\/Cas9","volume":"128","author":"Giuliano","year":"2019","journal-title":"Curr Protoc Mol Biol"},{"key":"2025112418000325700_bib36","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose-response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"key":"2025112418000325700_bib37","first-page":"19","article-title":"Comparative mechanisms of action of proteasome inhibitors","volume":"25","author":"Wang","year":"2011","journal-title":"Oncology"},{"key":"2025112418000325700_bib38","doi-asserted-by":"crossref","first-page":"172458","DOI":"10.1155\/2015\/172458","article-title":"Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: impact on myeloma-induced alterations of bone remodeling","volume":"2015","author":"Accardi","year":"2015","journal-title":"Biomed Res Int"},{"key":"2025112418000325700_bib39","first-page":"217","article-title":"Spotlight on ixazomib: potential in the treatment of multiple myeloma","volume":"10","author":"Muz","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"2025112418000325700_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"2025112418000325700_bib41","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm400487c","article-title":"Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development","volume":"56","author":"Ding","year":"2013","journal-title":"J Med Chem"},{"key":"2025112418000325700_bib42","doi-asserted-by":"crossref","first-page":"30036","DOI":"10.1074\/jbc.M604674200","article-title":"Ribosomal stress couples the unfolded protein response to p53-dependent cell-cycle arrest","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"2025112418000325700_bib43","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1128\/MCB.21.13.4246-4255.2001","article-title":"Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)\/S transition","volume":"21","author":"Pestov","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2025112418000325700_bib44","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2010-07-295238","article-title":"Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells","volume":"117","author":"Dutt","year":"2011","journal-title":"Blood"},{"key":"2025112418000325700_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2021.05.004","article-title":"PSMD9 ribosomal protein network maintains nucleolar architecture and WT p53 levels","volume":"563","author":"Ud Din Farooqee","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2025112418000325700_bib46","doi-asserted-by":"crossref","first-page":"19990","DOI":"10.18632\/oncotarget.4598","article-title":"Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1alpha\/XBP1 pathway","volume":"6","author":"Namba","year":"2015","journal-title":"Oncotarget"},{"key":"2025112418000325700_bib47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2019.01.006","article-title":"p53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors","volume":"35","author":"Carugo","year":"2019","journal-title":"Cancer Cell"},{"key":"2025112418000325700_bib48","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/cdd.2017.96","article-title":"p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress","volume":"24","author":"Lopez","year":"2017","journal-title":"Cell Death Differ"},{"key":"2025112418000325700_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12185-016-2016-0","article-title":"Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma","volume":"104","author":"Ri","year":"2016","journal-title":"Int J Hematol"},{"key":"2025112418000325700_bib50","first-page":"471","article-title":"Advances in the understanding of mechanisms and therapeutic use of bortezomib","volume":"12","author":"Mujtaba","year":"2011","journal-title":"Discov Med"},{"key":"2025112418000325700_bib51","doi-asserted-by":"crossref","first-page":"e0248140","DOI":"10.1371\/journal.pone.0248140","article-title":"Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening","volume":"16","author":"Grad","year":"2021","journal-title":"PLoS One"},{"key":"2025112418000325700_bib52","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/emm.2017.112","article-title":"Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"key":"2025112418000325700_bib53","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1080\/10428194.2020.1775204","article-title":"Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display antitumor activity in a xenograft model of bortezomib-resistant waldenstrom macroglobulinemia","volume":"61","author":"Madamsetty","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2025112418000325700_bib54","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10637-019-00840-1","article-title":"Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma","volume":"38","author":"Gluck","year":"2020","journal-title":"Invest New Drugs"},{"key":"2025112418000325700_bib55","doi-asserted-by":"crossref","first-page":"106222","DOI":"10.1016\/j.leukres.2019.106222","article-title":"Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: a systematic review of the literature","volume":"86","author":"Pi","year":"2019","journal-title":"Leuk Res"},{"key":"2025112418000325700_bib56","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1038\/s41598-022-16455-1","article-title":"Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup","volume":"12","author":"Martinez-Monleon","year":"2022","journal-title":"Sci Rep"},{"key":"2025112418000325700_bib57","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","article-title":"Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity","volume":"11","author":"Newell","year":"2020","journal-title":"Nat Commun"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-22-3173\/3332375\/can-22-3173.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/15\/2543\/3351887\/2543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/15\/2543\/3351887\/2543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:00:22Z","timestamp":1764025222000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/83\/15\/2543\/728076\/Proteasome-Inhibition-Sensitizes-Liposarcoma-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":57,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,5,19]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-3173","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30701470","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814630","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027890","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027904.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027901.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027895","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027904","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027898.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814627.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814621","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814633","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027895.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027907.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814618","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814621.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814624.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701461","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814639.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701473","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814636.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814633.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814630.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027893.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027890.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814624","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814636","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027910.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027910","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814618.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701452","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701476","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701464","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814639","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814627","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027893","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027898","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.27027907","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701467","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30701455","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.23814636","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814624","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6769314.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814630.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6769314","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814621","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814633","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6769314.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814630","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814618","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814636.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814639.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814621.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814633.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814624.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814627.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814639","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814618.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.23814627","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}